Marion Rudolph

488 total citations
18 papers, 390 citations indexed

About

Marion Rudolph is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Marion Rudolph has authored 18 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Marion Rudolph's work include Cancer Genomics and Diagnostics (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and T-cell and B-cell Immunology (3 papers). Marion Rudolph is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and T-cell and B-cell Immunology (3 papers). Marion Rudolph collaborates with scholars based in Germany, United States and Switzerland. Marion Rudolph's co-authors include Monika C. Brunner‐Weinzierl, Katrin Hebel, Isabella Gashaw, Astrid Menning, Hyun‐Dong Chang, Simon Fillatreau, Dagmar Quandt, Holger Hoff, Sabine Riethdorf and Carol E. Peña and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Marion Rudolph

18 papers receiving 383 citations

Peers

Marion Rudolph

IMMUN

ONCOL

PRM

Eric C. Yang Canada

Valentina Iacobelli Italy

C Villena-Heinsen Germany

Liangqing Yao China

Wenyan Wang China

Danyi Zhou Canada

Diana P. English United States

Malee Warnnissorn Thailand

Olga Kim South Korea

Tomokazu Umezu Japan

Eric C. Yang Canada

Marion Rudolph

92 ×0.7

IMMUN

182 ×1.5

132 ×1.4

ONCOL

51 ×0.6

PRM

34 ×0.5

Citations per year, relative to Marion Rudolph Marion Rudolph (= 1×) peers Eric C. Yang

Countries citing papers authored by Marion Rudolph

Since Specialization

Citations

This map shows the geographic impact of Marion Rudolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Rudolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Rudolph more than expected).

Fields of papers citing papers by Marion Rudolph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Rudolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Rudolph. The network helps show where Marion Rudolph may publish in the future.

Co-authorship network of co-authors of Marion Rudolph

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Rudolph. A scholar is included among the top collaborators of Marion Rudolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Rudolph. Marion Rudolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Shi, Xiaoliang, Weifeng Wang, Lin Zhang, et al.. (2023). Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China. npj Precision Oncology. 7(1). 75–75. 4 indexed citations

Williams, Michelle D., et al.. (2022). 1648P Deep learning identifies oncogenic genetic alterations in BRAF and NTRK in H&E whole slide images from thyroid carcinomas. Annals of Oncology. 33. S1296–S1296. 1 indexed citations

Rudzinski, Erin R., Jaclyn F. Hechtman, Sinchita Roy‐Chowdhuri, et al.. (2021). Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib. Cancer Genetics. 260-261. 46–52. 9 indexed citations

Drilon, Alexander, Shivaani Kummar, Catherine M. Albert, et al.. (2021). Abstract CT020: Long-term outcomes of patients with TRK fusion cancer treated with larotrectinib. Cancer Research. 81(13_Supplement). CT020–CT020. 3 indexed citations

Hong, David S., Afshin Dowlati, Howard A. Burris, et al.. (2020). Abstract CT062: Efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations. Cancer Research. 80(16_Supplement). CT062–CT062. 2 indexed citations

Schneeweiß, Andreas, Dagmar Hess, Markus Joerger, et al.. (2019). Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer—Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy. Cancers. 11(12). 1987–1987. 10 indexed citations

Schneeweiß, Andreas, Markus Joerger, Andréa Varga, et al.. (2019). Abstract CT015: Phase I dose-escalation study of the allosteric AKT inhibitor BAY 1125976 in advanced solid cancer. Cancer Research. 79(13_Supplement). CT015–CT015. 1 indexed citations

Rudolph, Marion, Steven T. Sizemore, Yuanzhi Lu, et al.. (2018). A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. Breast Cancer Research and Treatment. 169(3). 457–467. 7 indexed citations

Rudolph, Marion, Tobias Anzeneder, Georg Beckmann, et al.. (2016). AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection. BMC Cancer. 16(1). 622–622. 66 indexed citations

10.

Gorges, Tobias M., Sabine Riethdorf, Oliver von Ahsen, et al.. (2016). Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer. Oncotarget. 7(23). 34930–34941. 83 indexed citations

11.

Rudolph, Marion, Tobias Anzeneder, Matthias Ocker, et al.. (2014). Abstract 569: AKT1 (E17K) mutation: coexistence with oncogenic alterations, prevalence, and correlation to clinical parameter in a large series of breast cancer patients. Cancer Research. 74(19_Supplement). 569–569. 1 indexed citations

12.

Rudolph, Marion, Wolf‐Dietrich Döcke, A.R Müller, et al.. (2012). Induction of Overt Menstruation in Intact Mice. PLoS ONE. 7(3). e32922–e32922. 37 indexed citations

13.

Menning, Astrid, et al.. (2012). Granulocytes and Vascularization Regulate Uterine Bleeding and Tissue Remodeling in a Mouse Menstruation Model. PLoS ONE. 7(8). e41800–e41800. 27 indexed citations

14.

Hebel, Katrin, et al.. (2011). IL-1β and TGF-β Act Antagonistically in Induction and Differentially in Propagation of Human Proinflammatory Precursor CD4+ T Cells. The Journal of Immunology. 187(11). 5627–5635. 55 indexed citations

15.

Rudolph, Marion, Katrin Hebel, Yoshinori Miyamura, Emanual Maverakis, & Monika C. Brunner‐Weinzierl. (2011). Blockade of CTLA-4 Decreases the Generation of Multifunctional Memory CD4+ T Cells In Vivo. The Journal of Immunology. 186(10). 5580–5589. 18 indexed citations

16.

Quandt, Dagmar, Holger Hoff, Marion Rudolph, Simon Fillatreau, & Monika C. Brunner‐Weinzierl. (2007). A New Role of CTLA-4 on B Cells in Thymus-Dependent Immune Responses In Vivo. The Journal of Immunology. 179(11). 7316–7324. 39 indexed citations

17.

Rudolph, Marion, et al.. (1992). Clinical Pharmacokinetics of Moxonidine. Journal of Cardiovascular Pharmacology. 20(Supplement 4). S37–S41. 18 indexed citations

18.

Rudolph, Marion, et al.. (1986). Adrenergic mechanisms in the control of myometrial activity in mice. Changes on estrous cycle. Life Sciences. 38(22). 2043–2051. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact